DDInter459 DDInter1180
Cyproheptadine is a potent competitive antagonist of both serotonin and histamine receptors. It is used primarily to treat allergic symptoms, though it is perhaps more notable for its use in appetite stimulation and its off-label use in the treatment of serotonin syndrome.
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Cyproheptadine {u} (Compound) resembles {v} (Compound) Metixene
Cyproheptadine {u} (Compound) resembles {v} (Compound) Nortriptyline
Cyproheptadine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Methdilazine
Cyproheptadine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Protriptyline
Cyproheptadine {u} (Compound) treats {v} (Disease) allergic rhinitis
Cyproheptadine {u} (Compound) binds {v} (Gene) UGT1A3
Cyproheptadine {u} (Compound) upregulates {v} (Gene) KAT6A
Cyproheptadine {u} (Compound) palliates {v} (Disease) migraine
Cyproheptadine {u} (Compound) downregulates {v} (Gene) RPA1
Cyproheptadine {u} (Compound) causes {v} (Side Effect) Agranulocytosis
Cyproheptadine (Compound) resembles Metixene (Compound)
Cyproheptadine (Compound) resembles Nortriptyline (Compound)
Cyproheptadine may cause a moderate interaction that could exacerbate diseases when taken with Methdilazine
Cyproheptadine may cause a moderate interaction that could exacerbate diseases when taken with Protriptyline
Cyproheptadine (Compound) treats allergic rhinitis (Disease)
Cyproheptadine (Compound) binds UGT1A3 (Gene)
Cyproheptadine (Compound) upregulates KAT6A (Gene)
Cyproheptadine (Compound) palliates migraine (Disease)
Cyproheptadine (Compound) downregulates RPA1 (Gene)
Cyproheptadine (Compound) causes Agranulocytosis (Side Effect)